Soleno Therapeutics, Inc. (SLNO)
52.74
-0.08
(-0.16%)
USD |
NASDAQ |
Apr 24, 14:54
Soleno Therapeutics EPS Diluted (Quarterly) : 0.7904 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.482 |
| Nektar Therapeutics | -1.778 |
| Forian, Inc. | -0.0587 |
| Boston Scientific Corp. | 0.897 |
| Integer Holdings Corp. | 1.383 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 42.94M |
| Revenue (Quarterly) | 91.73M |
| Total Expenses (Quarterly) | 48.79M |
| Enterprise Value | 2.474B |
| Gross Profit Margin (Quarterly) | 99.06% |
| Profit Margin (Quarterly) | 46.81% |
| Earnings Yield | 0.42% |
| Operating Earnings Yield | 0.55% |
| Normalized Earnings Yield | 0.5724 |